Inventor · disambiguated record
Lars Hellman
Also filed as: HELLMAN LARS · HELLMAN LARS T
4 granted patents·7 pending applications·62 citations·filing 1992–2010
76Inventor score
Files withRESISTENTIA PHARMACEUTICALS AB4THERAVAC PHARMACEUTICALS AB2HELLMAN LARS T1HOLMDAHL RIKARD1OLSSON ANNA-KARIU1
Top patents by PatentIndex Score
11 records- 0174US5653980AVaccine comprising part of constant region of IgE for treatment of IgE-mediated allergic reactionsFiled 1992·Granted Aug 5, 1997·47 cites·9 claims
- 0262US7361742B2Methods and materials for treating inflammatory conditionsRESISTENTIA PHARMACEUTICALS AB·Filed 2003·Granted Apr 22, 2008·2 cites·5 claims
- 0359US7459158B2Immunogenic polypeptides for inducing anti-self IgE responsesRESISTENTIA PHARMACEUTICALS AB·Filed 2002·Granted Dec 2, 2008·1 cites·27 claims
- 0456US6913749B2Immunogenic polypeptides for inducing anti-self IgE responsesRESISTENTIA PHARMACEUTICALS AB·Filed 1999·Granted Jul 5, 2005·12 cites·3 claims
- 0554US2009191268A1Allergy vaccinesHELLMAN LARS T·Filed 2008·Application pending·0 cites
- 0653US2008262197A1Methods and materials for treating inflammatory conditionsHOLMDAHL RIKARD·Filed 2008·Application pending·0 cites
- 0753US2004054146A1Allergy vaccinesFiled 2003·Application pending·0 cites
- 0848US2004076625A1Enhanced vaccinesRESISTENTIA PHARMACEUTICALS AB·Filed 2003·Application pending·0 cites
- 0942US2010203008A1Novel compositions for the treatment of verious inflammatory conditionsTHERAVAC PHARMACEUTICALS AB·Filed 2007·Application pending·0 cites
- 1042US2010021486A1Tslp vaccine for the treatment of th2 mediated inflammatory conditionsTHERAVAC PHARMACEUTICALS AB·Filed 2007·Application pending·0 cites
- 1134US2013122028A1Novel vaccine that targets tumor vessels as an efficient tool in tumor therapyOLSSON ANNA-KARIU·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →